Similar articles

• Hemodynamic measurements as aids to choosing drug treatment of essential hypertension.

  Chen HC. Chen HC. Clin Ther. 1985;7(2):176-80. Clin Ther. 1985. PMID: 3986862
• [Results of long-term therapy of arterial hypertension].

  Reubi F. Reubi F. Schweiz Med Wochenschr. 1973 Nov 24;103(47):1690-2. Schweiz Med Wochenschr. 1973. PMID: 4594047 Review. French. No abstract available.
• [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].

  Pozenel H. Pozenel H. Wien Klin Wochenschr. 1969 Mar 14;81(11):187-92. Wien Klin Wochenschr. 1969. PMID: 4935483 German. No abstract available.
• Essential malignant hypertension. Clinicopathologic correlations.

  Susin M, Mailloux LU. Susin M, et al. N Y State J Med. 1978 Jan;78(1):54-8. N Y State J Med. 1978. PMID: 272499 No abstract available.
• [Benefits and risks of hypertension therapy from the cardiac viewpoint].

  Motz W, Strauer BE. Motz W, et al. Z Kardiol. 1994 Mar;83(3):179-87. Z Kardiol. 1994. PMID: 8178541 Review. German.